Latest KFF Health News Stories
How Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
Fentanyl and other painkillers marketed as safer than Purdue Pharma’s blockbuster drug left their own trail of overdose deaths.
Pacientes con dolor crónico se sienten atrapados en el debate sobre opioides
Los pacientes que necesitan esta medicación se sienten afectados injustamente por la tendencia a recetarlos cada vez menos, como una estrategia para frenar la creciente epidemia de abuso de opioides.
Patients With Chronic Pain Feel Caught In An Opioid-Prescribing Debate
States are passing laws that limit a doctor’s ability to prescribe opioids. Doctors and patients alike are wrestling with what that means in cases of chronic pain.
Readers And Tweeters: On Seniors Packing Heat And When They Should Pack It In
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Purdue Pharma Edits Public Service Ad In Washington Post
Did OxyContin maker admit opioids can be dangerous even when patients take them as prescribed — then walk it back?
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Facebook Live: The Marketing Plan That Fueled An Addiction Epidemic
KHN senior correspondent Fred Schulte talks about a cache of files detailing Purdue Pharma’s early OxyContin marketing plan.
What A U.S.-China Trade War Could Mean For The Opioid Epidemic
The nation’s effort to combat this public health crisis could get caught in the crossfire of the Trump administration’s trade policies.
Tennessee-Based Pain Management Group To Close Clinics Amid Financial Turmoil
The CEO of Comprehensive Pain Specialists was indicted in April. Now the group is closing clinics across several states.
Readers And Tweeters Let Loose Over Kids Being Detained At The Border — And More
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Doling Out Pain Pills Post-Surgery: An Ingrown Toenail Not The Same As A Bypass
As the opioid epidemic rages, a Johns Hopkins surgeon and researcher is leading an effort to curb overprescribing by offering procedure-specific guidelines to ensure that post-surgical patients leave the hospital with enough, but not too much, pain medication.
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
In New Hampshire, Even Mothers In Treatment For Opioids Struggle To Keep Children
New Hampshire parents who are trying to overcome opioid abuse face a ticking clock and limited state resources to try to keep their parental rights.
How America Got Hooked On A Deadly Drug
An inside look at how Purdue Pharma pushed OxyContin despite risks of addiction and fatalities.
Must-Reads Of The Week From Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Best Reads Of The Week With Brianna Labuskes
KHN’s newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don’t have to.
Podcast: KHN’s ‘What The Health?’ Much Ado About Drug Prices
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call discuss President Donald Trump’s proposals to control prescription drug prices and the efforts to sell the plan to lawmakers and the public. Also, Rovner interviews emeritus law professor Timothy Jost about the state of the Affordable Care Act.
Dramático aumento de muertes por sobredosis de opioides en latinos. ¿Por qué?
Nuevos datos muestran que la epidemia de opioides está cambiando de cara, y que ya no es un problema exclusivo de los blancos no hispanos.
